Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ileal sodium/bile acid cotransporter, commonly known as the apical sodium-dependent bile acid transporter (ASBT) or ileal bile acid transporter (IBAT), is a transmembrane protein primarily expressed on the apical membrane of enterocytes in the terminal ileum. It plays a critical role in the enterohepatic circulation of bile acids by actively reabsorbing conjugated and unconjugated bile acids from the intestinal lumen in a sodium-dependent manner. This reabsorption process is essential for maintaining bile acid and cholesterol homeostasis. Dysregulation or genetic mutations in this transporter can lead to primary bile acid malabsorption, characterized by chronic diarrhea and steatorrhea.
In pharmacological contexts, this transporter is a highly attractive therapeutic target. Inhibiting its activity prevents the reabsorption of bile acids, promoting their excretion in feces and reducing systemic bile acid levels. This mechanism is utilized by approved drugs to treat severe cholestatic pruritus in rare genetic liver disorders like Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), as well as primary biliary cholangitis (PBC). Additionally, inhibitors of this transporter are used to treat chronic constipation. Safety concerns associated with its inhibition include gastrointestinal side effects such as diarrhea and abdominal pain, potential hepatotoxicity, and deficiencies in fat-soluble vitamins (A, D, E, and K) which can lead to bleeding complications.
Inhibition of the apical sodium-dependent bile acid transporter (ASBT/IBAT) to block the reabsorption of bile acids in the terminal ileum, thereby reducing systemic bile acid levels and promoting fecal excretion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ileal sodium/bile acid cotransporter (ASBT).